FNU Vikas

About

Dr. Vikas is a postdoctoral researcher at the Masonic Medical Research Institute, Utica, NY, USA, developing precision nanomedicine platforms for lupus, cardiovascular diseases, and bone regeneration. He specializes in polymer modification, targeted nanoparticle engineering, and advanced drug delivery strategies to create safe and effective therapeutics. In addition to his research, he mentors students, engages in STEM outreach, and contributes as a peer reviewer for high-impact journals, supporting both scientific advancement and the next generation of scientists.

Employment

• SUNY Polytechnic Institute Adjunct Faculty – CHEM 130L: Introductory Chemistry Laboratory
  2025 - 2025
• MMRI POSTDOCTRAL RESERCHER
  2023 - Present

Education

• Indian Institute of Technology BHU Varanasi Ph.D.
  2018 - 2023
• Pandit Bhagwat Dayal Sharma University of Health Sciences College of Nursing B. PHARM
• Dr Hari Singh Gour University M. PHARM

Projects & Funding

Projects & funding information is unavailable.

Publications (35)

• Microneedles for Anticancer Drug Delivery
  Advanced Cancer Therapeutics: Strategies and Technologies for Targeted Drug Delivery 2026
  +Save
• Exploring age-related biodistribution of angiotensin-II receptor-based nanomedicine in lupus mouse model [poster presentation]. In: BME II 13 Symposium; Icahn School of Medicine at Mount Sinai, NY, USA
  BME II 13 Symposium, Icahn School of Medicine at Mount Sinai, New York 2025
  +Save
• Fluorescent Calcium Nanocluster-Driven Theranostic Nanoplatforms for Advanced Imaging and Therapy in Breast Tumor
  ACS Applied Nano Materials 2025 DOI: 10.1021/acsanm.4c06929
  +Save
• Targeted Nanomedicine and Drug Delivery
  SUNY Polytechnic Institute 2024
  +Save
• Nanofibers of N,N,N-trimethyl chitosan capped bimetallic nanoparticles: Preparation, characterization, wound dressing and in vivo treatment of MDR microbial infection and tracking by optical and photoacoustic imaging
  International Journal of Biological Macromolecules 2024 DOI: 10.1016/j.ijbiomac.2024.130154
  +Save
• Cetuximab decorated redox sensitive D-alpha-tocopheryl- polyethyleneglycol-1000-succinate based nanoparticles for cabazitaxel delivery: Formulation, lung targeting and enhanced anti-cancer effects
  International Journal of Pharmaceutics 2024 DOI: 10.1016/j.ijpharm.2024.123881
  +Save
• Biomimetic Nanomaterials for the Immunomodulation of the Cardiosplenic Axis Postmyocardial Infarction
  Advanced Materials 2024 DOI: 10.1002/adma.202304615
  +Save
• Alginate-Based Hydrogels as Drug Carriers
  Biomaterial-based Hydrogels 2024 DOI: 10.1007/978-981-99-8826-6_2
  +Save
• Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging
  Nanotheranostics 2024 DOI: 10.7150/ntno.94364
  +Save
• Synthesis and processing methods of magnetic nanosystems for diagnostic tools and devices: Design strategies and physicochemical aspects
  Functionalized Magnetic Nanosystems for Diagnostic Tools and Devices 2024 DOI: 10.1016/b978-0-443-19012-4.00010-2
  +Save